福泰製藥公司
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSuntrust Banks Inc
Latest Disclosed Ownership17,785 shares
Latest Disclosed Value $ 3,014,000
Suntrust Banks Inc reports 12.24% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On November 12, 2019 - Suntrust Banks Inc filed a 13F-HR form disclosing ownership of 17,785 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $3,013,135 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 6, 2019 disclosing 15,846 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 12.24% during the quarter. The current value of the position is $7,946,872 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,785 1,939 12.24 3,014 3.72 0.0157
2019-08-06 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,846 1,372 9.48 2,906 9.17 0.0151
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,474 854 6.27 2,662 17.94 0.0140
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 13,620 1,062 8.46 2,257 -6.77 0.0130
2019-09-04 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 12,558 3,297 35.60 2,421 53.81 0.0125
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 12,564 3,303 2,421
2019-09-04 2018-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 9,261 555 6.37 1,574 10.92 0.0086
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,974 -21,695 1,693
2019-09-04 2018-03-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 8,706 2,603 42.65 1,419 55.25 0.0079
2018-05-25 2018-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 31,669 22,963 5,160 0.0271
2018-05-14 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 29,681 -181 4,836
2019-09-03 2017-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 6,103 -18,310 -75.00 914 -75.38 0.0053
2018-02-09 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 29,862 2,925 4,474
2019-09-03 2017-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 24,413 1,918 8.53 3,712 28.04 0.0220
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 26,937 4,442 4,095
2019-09-04 2017-06-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 22,495 3,126 16.14 2,899 36.87 0.0177
2019-09-03 2017-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 22,495 0 2,899 0.0177
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 26,825 3,460 3,456
2019-09-03 2017-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 19,369 -1,220 -5.93 2,118 39.80 0.0135
2017-05-03 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,365 2,776 2,554
2017-02-09 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 20,589 -768 -3.60 1,515 -18.59 0.0091
2016-11-09 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 21,357 966 4.74 1,861 6.16 0.0116
2016-08-02 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 20,391 -1,026 -4.79 1,753 3.06 0.0107
2016-05-09 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 21,417 5,961 38.57 1,701 -12.50 0.0105
2016-02-10 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,456 11,655 306.63 1,944 628.09 0.0120
2014-05-14 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,801 -182 -4.57 267 -9.18 0.0010
2014-02-12 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,983 -1,110 -21.79 294 -23.44 0.0011
2013-11-04 2013-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 5,093 -25,673 -83.45 384 -84.39 0.0015
2013-10-31 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,093 384
2013-09-06 2013-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 30,766 30,766 2,460 0.0108
2013-08-15 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 30,766 2,460
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.